Novo Nordisk's parent company will buy Catalent to expand Wegovy supply
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
health care industry
J&J, Merck and Bristol Myers Squibb on the bench
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Good afternoon!…
Non-opioid pain reliever Vertex shows positive results in late-stage trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston on Oct. 23, 2019. Brian Snyder | Reuters…
GSK sees huge RSV vaccine sales, raises outlook
The logo of pharmaceutical company GlaxoSmithKline is seen at its facility in Stevenage, Britain, October 26, 2020. Ruvic Dice |…
Biogen abandons Alzheimer's drug Aduhelm to focus on Leqembi, others
Biogen headquarters in Cambridge, Massachusetts, on October 24, 2023. vanessa leroy | Bloomberg | fake images biogen on Wednesday said…
We're cutting healthcare stocks ahead of earnings, hedging our bets on China deals
We are selling 95 shares of GE Healthcare at approximately $74. Following Wednesday's transaction, Jim Cramer's Charitable Trust will own…
Novo Nordisk Reaches $500 Billion in Market Value as It Points to Growing Demand for Wegovy and Ozempic
Liselotte Sabroe | afp | fake images Novo Nordisk on Wednesday reported better-than-expected profits for 2023 as sales of its…
Norwegian fund says Novo and Eli Lilly could join trillion-dollar club
A pharmacist displays boxes of Ozempic, an injectable semaglutide drug used to treat type 2 diabetes manufactured by Novo Nordisk,…
Neuralink competitor Synchron buys equity stake in the manufacturer
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet…
Advertising giant Publicis pays $350 million to settle US opioid claims
A Publicis Groupe SA sign at its headquarters in Paris, France, Sunday, July 28, 2013. Balint Porneczi | Bloomberg |…